THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY. FURTHER DETAILS OF THE FUNDRAISING ARE SET OUT BELOW.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF TRACKWISE DESIGNS PLC.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Terms not otherwise defined herein shall have the meanings given in the section entitled "Definitions" at the end of this Announcement.

TRACKWISE DESIGNS PLC

("Trackwise", the "Company" or the "Group")

Placing via Accelerated Bookbuild, Subscription and Open Offer

Issue of Warrants and Capital Reorganisation

Board Changes

and

Notice of General Meeting

Trackwise Designs (AIM: TWD), a leading manufacturer of specialist products using printed circuit technology, is pleased to announce a proposed conditional placing to raise gross proceeds of £3.65 million by way of the issue of an aggregate of up to 364,524,700 New Ordinary Shares pursuant to a Placing of up to 364,224,700 New Ordinary Shares and a Subscription of 300,000 New Ordinary Shares at an Issue Price of 1 pence per New Ordinary Share.

finnCap is acting as sole Bookrunner in connection with the Placing. The Placing will be conducted by way of an accelerated Bookbuild, which will be launched immediately following this Announcement, in accordance with the terms and conditions set out in the Appendix to this Announcement.

In addition, the Company proposes to raise up to a further approximately £1.5 million by the issue of up to 149,999,860 New Ordinary Shares pursuant to an Open Offer to Qualifying Shareholders, on the basis of 1 Open Offer Share for every 0.250054 Existing Ordinary Shares held on the Record Date, also at the Issue Price (the Placing, Subscription and Open Offer, together the "Fundraising").

The Company also proposes to issue Warrants to subscribers in the Placing, Subscription and Open Offer granting rights to subscribe for 1 additional Ordinary Share for each Warrant held in the ratio of 1 Warrant for every 2 New Ordinary Shares issued to those subscribers (the "Warrants"). The Warrants are exercisable at a price of 6 pence per Ordinary Share during the three year Warrant Exercise Period.

The Fundraising requires Shareholder Resolutions to be passed by the Company's Shareholders.

Highlights:

Philip Johnston, CEO of Trackwise, commented:

"It is of course a matter of deep regret that we have found ourselves forced to come to the market on these terms. We very much appreciate the support shown by existing investors and welcome new shareholders to Trackwise. We look forward to commencing production at Stonehouse for our EV OEM customer, and continue to work hard to convert our IHT sales pipeline into new production contracts.

"I would like to thank Ian, Susan and Charles for their contribution to Trackwise and I am very much looking forward to working with Andrew and Chris."

Open Offer

Further details are provided below.

Circular and General Meeting

A Circular to Shareholders in respect of the Placing, Subscription and the Open Offer is expected to be posted to shareholders on 15 December 2022 giving notice of a General Meeting of the Company. The meeting will be held on 6 January 2022 at 10:00 a.m. at the offices of the Trackwise at 1 Ashvale, Alexandra Way, Tewkesbury GL20 8NB. Following posting, a copy of the Circular will available on 15 December 2022 on the Company's website www.trackwise.co.uk.

In proposing the terms of the Fundraising, the Board has pursued a number of routes to raising funds including agreeing the advance payment from the UK EV OEM. However, the Board believes it has now exhausted any potentially more attractive routes that could have been capable of delivering sufficient funds in time with sufficient certainty and has been left with no alternative but to proceed with the Fundraising at a very significant discount and with the issue of the Warrants. The Board understands the implications for Shareholders and has given Shareholders who have not participated in the Placing the opportunity to participate in the fundraising through the Open Offer.

Shareholders should be aware that if the Resolutions are not approved at the General Meeting, the Fundraising will not occur and the net proceeds will not be received by the Company. If this were to happen, to continue to trade, the Group would have to find urgent alternative funding and the Board do not believe that sufficient funding would be available in time to avoid an insolvency event.

The Directors believe that the Resolutions to be proposed at the General Meeting are in the best interests of the Company and Shareholders as a whole and unanimously recommend that Shareholders vote in favour of the Resolutions. The Directors intend to vote in favour of all of the Resolutions in respect of, in aggregate, 6,854,143 Existing Ordinary Shares, representing approximately 18.27 per cent. of the Existing Ordinary Shares.

Accelerated Bookbuild

The timing for the close of the Bookbuild and allocation of the Placing Shares shall be at the absolute discretion of finnCap, in consultation with the Company. The final number of Placing Shares to be issued pursuant to the Placing will be agreed by finnCap and the Company at the close of the Bookbuild. The result of the Placing will be announced as soon as practicable thereafter. The Placing is not underwritten. The Placing Shares are not subject to clawback and are not part of the Open Offer.

¹ Based on Directors' expectations of OEMs A, B, C, E , F & G demand and pricing

Further information on the Fundraising, including the Open Offer, is set out below. This announcement should be read in its entirety.

Enquiries

Notes to editors

Trackwise is a UK-based manufacturer of specialist products using printed circuit technology.

The full suite includes: Improved Harness Technology™ ("IHT") and Advanced PCBs - Microwave and Radio Frequency ("RF"), Short Flex, Flex Rigid and Rigid Multilayer products.

IHT uses a proprietary, patented process that Trackwise has developed to manufacture multilayer flexible printed circuits of unlimited length. While the technology has many applications, the directors expect that one of its primary uses will be to replace traditional wire harnesses in a variety of industries.

The Company operates from three sites, located in Tewkesbury, Stonehouse and Stevenage. It serves customers in Europe and North America.

Trackwise Designs plc was admitted to trading on AIM in 2018 with the ticker TWD. For additional information please visit www.trackwise.co.uk

The following text has been taken from the Circular to be sent to Shareholders.

LETTER FROM THE CHAIRMAN

1.    Introduction

The Company announced on 14 December 2022 that it had conditionally raised £3.65 million (before expenses) by the issue of up to 364,224,700 New Ordinary Shares pursuant to the Placing and the Subscription of a total of up to 300,000 New Ordinary Shares both at 1.0 pence per share (the "Issue Price"). In addition, the Company announced an Open Offer providing an opportunity for Qualifying Shareholders, to raise gross proceeds of approximately £1.50 million by the issue of up to 149,999,860 New Ordinary Shares also at the Issue Price.

The Company proposes to issue Warrants to subscribers in the Placing, Subscription and the Open Offer, granting rights to subscribe for additional Ordinary Shares held in the ratio of one Warrant for every two New Ordinary Shares. The Warrants are exercisable at a price of 6 pence per Ordinary Share during the three year Warrant Exercise Period.

The Fundraising is conditional on, inter alia, the passing of the Resolutions by the Shareholders at the General Meeting. If the Resolutions are passed, the New Ordinary Shares are expected to be allotted immediately after the General Meeting, conditional on Admission, which is expected to occur at 8.00 a.m. on 9 January 2023. Should Shareholder approval not be obtained at the General Meeting, neither the Placing, the Subscription nor the Open Offer will proceed. None of the Placing, the Subscription nor the Open Offer has been underwritten.

The purpose of this letter is to outline the reasons for the Fundraising, details of the Open Offer and explain why the Board considers the Resolutions to be in the best interests of the Company and Shareholders as a whole, and why the Directors unanimously recommend that you vote in favour of all of the Resolutions, as they intend to in respect of the Ordinary Shares held by them, which represent in aggregate approximately 18.27 per cent. of the Existing Ordinary Shares.

Shareholders should be aware that if the Resolutions are not approved at the General Meeting, the Fundraising will not occur and the net proceeds will not be received by the Company. If this were to happen, to continue to trade, the Group would have to find urgent alternative funding and the Board do not believe that sufficient funding would be available in time to avoid an insolvency event.

2.    Background to and reasons for the Fundraising

History and background

The Trackwise business has been trading since 1989 and was historically a provider of large antennae for the mobile phone industry. The business was acquired by the Company (formerly called Bremhold Limited and incorporated in 2000). In 2012 the Company began the development of Improved Harness TechnologyTM (IHT), being flexible multilayer printed circuit boards of unlimited length.

In 2014, a patent was granted to the Company in relation to the IHT manufacturing process in the United Kingdom. Patents have since been granted to the Company in the United States of America, Canada, the European Union, China and Brazil.

IHT is a disruptive process technology that enables the replacement of wire and wire harnesses in a wide variety of applications. Its key benefits, which are built on the longstanding and well-known benefits of flexible PCBs of short length, are that: it can reduce weight by up to 75 per cent. when replacing incumbent technology; improve precision, reliability and performance; and its ability to support distributed electronics or 'smart harness'. IHT is positioned to satisfy the demand for lighter, smaller and more functional connectivity across a range of applications, including in the EV, aerospace and medical industries.

The Company financed the development of the IHT process technology using the retained profits of its traditional antenna business as well as debt finance during the period up to 2018. In July 2018, the Company's shares were admitted to trading on the London Stock Exchange AIM market by way of an IPO, raising £5.5 million of new money. The funding provided at the time of IPO enabled the Company's development of capacity and capability to manufacture IHT and since then the Company has advanced the roll-to-roll manufacture of IHT to facilitate larger scale production of IHT.

In April 2020, the Company acquired Stevenage Circuits Limited (CRN: 01059497) ("SCL"). The Company has subsequently transferred its traditional antenna business to SCL, thereby allowing it to focus the Tewkesbury site on IHT.

Product Manufacture and Supply Agreement with EV OEM

In September 2020 the Company announced the culmination of 2 years' development work with a UK EV OEM (the "EV OEM") for the supply of flexible printed circuit boards for use in high voltage battery modules, made using the technology and know-how developed by the business for its IHT product. The contract (a product manufacture and supply agreement, the "PMSA") was extended in June 2021 to a 4 year contract and had the potential to generate revenues of up to £54 million over that period (previously up to £38 million).

Stonehouse Site acquisition

In April 2021 the Company acquired a 77,000 sq. ft. freehold property in Stonehouse, Gloucestershire ("Stonehouse Site") to enable the Company to significantly increase its production capacity to meet expected demand for its IHT products; with the Stonehouse Site to become a roll to roll flexible printed circuit manufacturing and assembly facility set up for high volume, low mix, and with the Tewkesbury site remaining an engineering led facility focused on IHT product development and new product introduction.

New Agreement with EV OEM

The Company's performance is closely linked to that of its first IHT production customer and the EV OEM announced on 11 August 2022 that it expected lower production volumes in 2022 compared to previous estimates. The announcement of the lower production volumes had a knock-on impact on the availability, to the Company, of the planned asset-backed debt funding for the remaining pieces of capital expenditure at the new Stonehouse Site and, in addition, increased the Company's short-term cash requirements. Accordingly, the Company entered in to discussions with the EV OEM and on 21 October 2022 replaced the PMSA with a new contractual agreement.

The new agreement (the "New Commercial Order") was entered into for a fixed quantity of flexible printed circuit boards due to be delivered through to July 2023. This New Commercial Order provided for a £3.99 million advanced payment, which was paid in October 2022, with the balance of the contract value (being an additional £3.99 million) satisfied by standard payments on delivery of the products.

The advanced payment is secured by a legal charge over various manufacturing assets involved in the production of the circuit boards at the Stonehouse Site. The charge will be released upon completion of the supply of the full contracted quantity. Completion of the new contract and release of the charge will conclude contractual arrangements between the two companies. Any further supply of existing parts, or development of new parts for the EV OEM, will be under new arrangements to be agreed with the EV OEM.

Stonehouse Site investment

Total investment at the Stonehouse Site is expected to total £24 million by the time of start of production. The Stonehouse Site factory refurbishment and fit out is now largely complete which, together with its purchase, has cost £6 million. Equipment installation and commissioning is nearing completion, with total spend at completion expected to be £13 million. Stonehouse Site project start-up costs will have totaled £5 million.

The Company expects to commence volume production at the Stonehouse Site for the EV OEM customer in Q1 of 2023, with first cash receipts for production parts expected in early April 2023. The first production shift are being recruited and trained although that has been delayed by the necessary fund raising process we have been going through, and production is planned to be complete by July 2023.

The Fundraising, together with cashflows from the New Commercial Order, are expected to fund the Company through to completion of the New Commercial Order in July 2023.

The Company sets out in this document, an Open Offer for Qualifying Shareholders to subscribe for Ordinary Shares at the Issue Price to enable shareholders to participate as they may wish.

3.    Use of proceeds

The Company is proposing to raise gross proceeds of £3.65 million from the Placing and Subscription to meet the funding requirement described above. The use of proceeds are expected to comprise:

Growth working capital, Stonehouse Site start-up costs, and contingency                                                 £0.40 million

Completion of Stonehouse Site capital expenditure                                                                                       £0.72 million

Interest and borrowing                                                                                                                                         £2.53 million

Total                                                                                                                                                                         £3.65 million

In addition, the proceeds of the Open Offer to provide headroom and                                                                   Up to

additional growth working capital                                                                                                                       £1.50 million

In the interim results for the six months ended 30 June 2022, the Company reported a loss before and after tax. The Board does not anticipate the Group to be cash generative in the second half of its 2022 financial year. It is anticipated that the Placing proceeds would give the Company an expected cash runway through to start of production of the New Commercial Order, and then upon completion of this production a further runway to August 2023. Any cash received from the Open Offer helps provide some contingency cover to deal with any potential risks associated with start of production. However, following completion of delivery of the parts pursuant to the New Commercial Order, and in the absence of significant new orders, the final four months of 2023 and beyond is expected to see further cash out flow from the business due to the Group's forecast cost base.

Therefore, the Fundraising is not expected to be sufficient to fund the cash requirements of the Group through to a position where it is able to fund itself from its own cashflow. It is likely that the Group will need to raise additional funding by the end of the third quarter of 2023 and, whilst the Directors believe that future funding may be available, potentially in the form of a strategic investment from an industry -based investor, there can be no guarantee that sufficient funds could be raised at a later date. Any additional equity financing, if available, may be dilutive to Shareholders.

4.    Information on the Fundraising and terms of the Placing Agreement

The Company proposes to raise £3.65 million (before expenses) through the issue of the Placing Shares and Subscription Shares at the Issue Price. The Issue Price represents a discount of 92.09 per cent. to the closing mid-market price of an Ordinary Share of 12.65 pence on 13 December 2022, being the Business Day prior to the announcement of the Fundraising.

Pursuant to the terms of the Placing Agreement finnCap, as agent and broker for the Company, has conditionally agreed to use its reasonable endeavours to place the Placing Shares with certain institutional and other investors through an accelerated bookbuild. The Placing Agreement is conditional upon, amongst other things, the Resolutions being duly passed at the General Meeting and Admission becoming effective on or before 8.00 a.m. on 9 January 2023 (or such later time and/or date as the Company and finnCap may agree, but in any event by no later than 5.30 p.m. on 27 January 2023).

The Placing Agreement contains warranties from the Company in favour of finnCap in relation to, amongst other things, the accuracy of the information in this document and other matters relating to the Company and its business. In addition, the Company has agreed to indemnify finnCap and their affiliates in relation to certain liabilities they may incur in respect of the Placing. finnCap can terminate the Placing Agreement at any time prior to Admission in certain circumstances, including in the event of a material breach of the warranties given in the Placing Agreement, the failure of the Company to comply with its obligations under the Placing Agreement, the occurrence of a force majeure event which in finnCap's opinion make it inadvisable or impractical to proceed with the Placing, or a material adverse change affecting the financial, operational or legal condition of the Company. If this right is exercised the Placing will not proceed. None of the Placing, Subscription or Open Offer are being underwritten by finnCap. The Company has agreed to pay certain fees and commissions to finnCap in respect of the Fundraising.

5.    Admission of the Placing, Subscription and Open Offer to AIM

Application will be made for the Placing Shares, the Subscription Shares and the Open Offer Shares to be admitted to trading on AIM. Conditional upon, inter alia, the passing of the Resolutions, it is anticipated that Admission will occur on or around 8.00 a.m. on 9 January 2023. The New Ordinary Shares will, if and when issued, rank pari passu in all respects with the Existing Ordinary Shares including the right to receive dividends and other distributions declared following Admission.

6.    Financial position, current trading and outlook

Net debt position

Net debt (cash and cash equivalents less plant and machinery asset financing, invoice discounting, and mortgage; excludes IFRS16 right of use lease liabilities) as at 30 November 2022 was approximately £8.48 million (unaudited) (31 December 2021: £2.10 million). Once the charge under the New Commercial Order is released the Company will have unencumbered assets with a cost of at least £4.0 million that would be available for refinancing. The Company expects to receive an R&D tax credit of £631,000 in cash in January 2023, and SCL expects to receive an R&D tax credit of £251,000 in cash in December 2022.

Current financial year trading

On 30 September 2022, the Company announced its interim results for the six months ended 30 June 2022 and the Company has a 31 December financial year end. The interim results included other operating income (not included in revenue) of £729,000, of which £698,000 was partial recognition of the estimated compensation which at the time was expected to be subsequently due as a result of the EV OEM's order shortfall against the guaranteed minimum volumes set out in the original contract; this was an estimate and subject to a significant degree of judgement in respect of the commercial negotiations. Following the publication of the interim results the commercial negotiations were concluded and the New Commercial Order was entered into. Under the terms of the New Commercial Order the Company will recognise revenue from the contract upon delivery of products, which is expected to begin in Q1 of 2023. As a result the Company will be unable to recognise any other operating income related to the New Commercial Order in the financial year ending 31 December 2022.

For the ten months to 31 October 2022, the Company, has achieved:

·      Total revenue of approximately £6.10 million (unaudited) (year to 31 December 2021: £8.01 million)

·      IHT revenue of £0.78 million (unaudited) (year to 31 December 2021: £1.48 million)

·      Adjusted* EBITDA of £0.17 million (unaudited) (earnings before interest, tax, depreciation and amortization) (year to 31 December 2021: £0.81 million)

·      Adjusted* operating loss of £1.50 million (unaudited) (year to 31 December 2021: loss of £0.58 million)

·      Loss before tax of £5.7 million (unaudited) (year to 31 December 2021: £1.98 million)

*Before share based payments (10 months ended 31 October 2022 of £0.03 million (unaudited) (year to 31 December 2021: £0.15 million) and exceptional costs (10 months ended 31 October 2022 of £3.83 million (unaudited), being new facility set up costs and inefficient production of initial volumes at the Ashvale facility (year to 31 December 2021: £0.94 million).

In the APCB division based in Stevenage at SCL, following a disappointing first half in 2022, a new managing director was appointed in July 2022; the business has started to see improved operations and performance, and this is expected to continue to improve in the medium term.

Orderbook, sales pipeline, and outlook

In addition to 2023 orders from the EV OEM pursuant to the New Commercial Order totaling £7.99 million, the Company has a further order book (IHT and APCB combined) of £2.75 million (unaudited) (of which £0.69 million is for delivery in the year ended 31 December 2022).

The Company's IHT sales pipeline includes potential new EV customers for Battery CCS (cell connection systems), including both cell-to-pack, and battery packs, including modules including the following:

Electric Vehicles (EV):

·      As shown in the table below there are CCS opportunities for six EV OEMs, totaling more than £1 billion of potential demand (based on Directors' expectations of OEMs A, B, C, E, F & G demand and pricing), with the Company as a Tier 1, or Tier 2 supplier.

·      CCS opportunity with one battery storage business.

Within an EV, individual cells (cylindrical, pouch, prismatic) need to be combined in parallel and/or in series to provide the required electrical performance and this combination can be done via intermediate building blocks - modules - with the modules subsequently built into a battery pack, or directly into a pack; cell-to-pack. From a vehicle perspective, cell-to-pack provides higher mass and volume integration efficiencies and from the Company's perspective, the cell-to-pack CCS are long - vehicle size (approx. 2metres) in length. The Company understands its long FPC manufacturing capability to be a key competitive advantage and therefore the cell-to-pack CCS opportunities (OEMs B, C and G) are a key focus for the business.

(1)   In Directors' opinion

(2)   SoP - Start of Production. Nominated supplier will be required to be 'off production tools' some months earlier

(3)   Following a Tier 1 nomination, any contract awards to the Company would not be expected to include volume commitments from the customer

(4)   A supplier nomination achieved by a Tier 1 supplier and potential customer is a key step in the process towards the Company working with the Tier 1 to enter into a Tier 2 supply contract

Aerospace:

Current Aerospace IHT development contracts include:

Project:                                       For:                        Status:                                              Entry Into Service - estimated

Aircraft cabin harness                EU OEM -              Development contract                      Approx. 2025

via Tier1                  Milestones through to TRL6

In flight aircraft deicing             EU OEM -              R&D program Innovate UK               Approx. 2025

via GKN                   Plan through to prototype

system verified ("TRL 6")

On ground aircraft deicing US Developer                Development orders with                2023-2024

planning through to flight
ready design

Business jet cabin harness US OEM                        Pre-production order with                2024

planning through to flight
ready designs

Electric aerospace                      UK and                   Development orders                         TBC

battery packs                              EU OEMs

Spacecraft Solar Array               EU OEM                 Development orders                         Approx. 2024

transfer harness

These Aerospace developments utilise the Double Belt Press (DBP), envisaged within the original IHT patent application in 2012 and now installed and commissioned at Stonehouse.

Subject to successful progress in-house and with our customers, 2023 will see IHT flight-qualified.

Medical:

As one of the three main market verticals that are the main focus for IHT for the Company, Medical has not progressed as far or as fast as expected. However, the multi-year agreement signed in April 2021 with CathPrint AB, the Stockholm-based company with expertise in the development and manufacturing of medical device products, is progressing to plan.

APCB Division:

The APCB Division sales pipeline includes:

·      New opportunities totaling £1.6 million with existing customers for heater rings, nuclear research, wireless technology and cyber security; and

·      Opportunities totaling £4.9 million with new customers for satellite dishes, nuclear research and medical devices.

Outlook

The prospects for IHT and for the Company are dominated by the EV CCS pipeline; in particular cell-to-pack and securing one or more supplier nominations is a key business objective. According to information available to the Company, Q1 and Q2 2023 will see supplier nominations for two major programs (OEMs B and C), with the Company in each case having summitted a submission to a Tier 1 in response to a request for proposal ("RFP") received by the Company.

These are large-scale programs and, as detailed above, the Company is seeking longer term strategic investment partnerships with larger global businesses, both to enhance our chances of securing and delivering these programs.

Strategic investment partnerships

The Company is actively exploring longer term strategic investment partnerships with larger global businesses in order to support development and conversion of the significant pipeline of identified IHT sales opportunities, notably for EV battery cell connection systems (CCS) for UK and EU OEMs, with the Company as a Tier 1 or Tier 2 supplier, and also for other Medical and Aerospace sales opportunities.

7.    Board changes and share options

Subject to completion of the Fundraising, it is proposed that Andrew Lapping and Chris Pennison will join the Board, as non-executive chairman, and non-executive director respectively; and in order to maintain the Board numbers and also to control the cost base, Susan McErlain and I have agreed to step down from the Board at the same time. Charles Cattaneo intends to step down from the Board at the end of January 2023. The new appointments are subject to satisfactory completion of the required AIM regulatory due diligence and completion of the Fundraising. Given the forthcoming departure of Charles Cattaneo, the Company will shortly commence a recruitment process for an additional new non-executive director.

Andrew Lapping and Chris Pennison represent a number of underlying new investors who, including Andrew and Chris, intend to invest in total approximately £1.21 million in the Placing, via Hamilton Capital Partners LLP. Included within this £1.21 million is Andrew's intention to invest £75,000 and Chris' intention to invest £25,000. The aggregate of these new beneficial interests would represent approximately 29.9 per cent. of the Enlarged Issued Share Capital at Admission assuming there is no Open Offer take up. The proposed annual remuneration for each new director is £30,000. Neither Andrew nor Chris would be considered as independent due to this investment in the Company.

Andrew Lapping, as well as founding Hamilton Capital Partners LLP, and previously being a non-executive director of Netplay TV plc, Legend Communications plc, Maven Income & Growth VCT 4 plc and SRT Marine Systems plc, was chairman and lead investor of Hyperdrive Innovation Holdings Ltd ("Hyperdrive"). Hyperdrive was successfully sold to the Turntide Technology group ("Turntide") in 2021. He was also lead investor and a director in CV Travel Holdings Ltd/Ski Verbier Ltd, which was sold to Kuoni, and automotive business DPE Auto Engineering Group Limited which was sold to Arlington Automotive.

Chris Pennison was the CEO of Hyperdrive, a developer and manufacturer of lithium-ion battery systems and helped lead the sale of Hyperdrive to Turntide in 2021. His current role is senior vice president strategic operations for Turntide working with all the business verticals across the Turntide group. He has held a number of senior positions in automotive tier 1 & 2 businesses, and has over 35 years of multi sector industrial experience.

Steve Hudson, currently Chief Operating Officer of the Company (non Board) is due to leave the Company at the end of the year and on behalf of the Board I would like to thank him for his contribution to the delivery of the Stonehouse Site and the negotiations with the EV OEM.

Following Admission the Board intends to conduct a review and re-incentivise all executive Directors, including CEO Philip Johnston, and senior members of staff with suitable equity based rewards.

8.    Director participation in the Placing, Subscription and Open Offer

The following Directors have agreed to subscribe for an aggregate of 5,300,000 Placing Shares and 300,000 Subscription Shares as set out below.

*Assuming the Open Offer is fully taken up

**Subscription for these Placing Shares by the wife of Philip Johnston

The Directors will not be participating in the Open Offer.

9.    Related Party Transaction

The Directors' aggregate participation in the Fundraising, as set out above, constitutes a related party transaction pursuant to Rule 13 of the AIM Rules. The Company's independent director (being Ian Griffiths) considers, having consulted with the Company's nominated adviser, finnCap, that the terms upon which the Directors are participating in the Fundraising are fair and reasonable insofar as the Company's shareholders are concerned.

10.  Proposed Capital Reorganisation of Ordinary Shares

The Company is not permitted by law to issue Ordinary Shares at an issue price which is below their nominal value, currently 4 pence per Ordinary Share. In order to enable the Company to issue shares at an issue price which is below their current nominal value, the Company is proposing to complete a Capital Reorganisation of the Ordinary Share capital of the Company. Each of the Existing Ordinary Shares will be subdivided into one New Ordinary Share of 0.1 pence each and one Deferred Share of 3.9 pence each.

The Capital Reorganisation will not of itself affect the value of the shares held by Shareholders. After the Capital Reorganisation, there will be the same number of Ordinary Shares in issue as there are Existing Ordinary Shares in issue (prior to completion of the Fundraising) and therefore your current shareholding will not be diluted by the Capital Reorganisation, unless a further equity fundraising is completed by the Company.

The New Ordinary Shares will have the same rights as those currently accruing to the Existing Ordinary Shares in issue under the Current Articles, including those relating to voting and entitlement to dividends. New share certificates for New Ordinary Shares will not be issued and the existing share certificates will remain valid.

The Deferred Shares will have no significant rights attached to them and carry no right to vote or participate in distribution of surplus assets and will not be admitted to trading on the AIM market of the London Stock Exchange plc. Therefore, the Deferred Shares will effectively carry no value.

Holders of Warrants or options over Existing Ordinary Shares will maintain the same rights as currently accruing to them and will not be issued with new warrant or option certificates.

Resolution 1 in the Notice of General Meeting, contained within the Circular, is proposed to sub-divide the Existing Ordinary Shares and Resolution 7 is proposed to adopt new Articles of Association, to include the rights attaching to the new Deferred Shares relative to the New Ordinary Shares. A copy of the New Articles will be available for inspection throughout the General Meeting.

General Meeting

The Directors do not currently have sufficient authority to allot in full the New Ordinary Shares. Accordingly, the Board is seeking the approval of Shareholders to allot the New Ordinary Shares at the General Meeting, together with approval to disapply pre-emption rights. Specific authorities are being sought at the General Meeting in respect of the New Ordinary Shares.

In addition, general authorities are being sought in substitution for those authorities given at the Company's Annual General Meeting in August 2022.

Shareholders should be aware that if any of the Resolutions are not passed, the Fundraising will not proceed. A notice convening the General Meeting, which is to be held at 10.00 a.m. on 6 January 2023 at the offices of the Company at 1 Ashvale, Alexandra Way, Tewkesbury, Gloucestershire GL20 8NB, is set out at the end of this document.

A Form of Proxy for use by the Shareholders in connection with the General Meeting is also enclosed. At the General Meeting, the following Resolutions will be proposed:

Resolutions 1,2 and 3 are an ordinary resolution and require a simple majority of those voting to vote in favour,. Resolutions 4, 5, 6, 7 and 8 are special resolutions and will require not less than 75 per cent. of those voting in person or on a poll by proxy to vote in favour.

11.  Issue of Warrants

The Company proposes to issue Warrants to subscribers in the Placing, the Subscription and the Open Offer, granting rights to subscribe for additional Ordinary Shares held in the ratio of one Warrant for every two New Ordinary Shares. The Warrants will be issued pursuant to the Warrant Instrument and will be exercisable at a price of 6p per Ordinary Share during the Warranty Exercise Period.

If (assuming full take up under the Open Offer) all of the Warrants are exercised in full the Company will receive gross proceeds of a further £15.44 million.

The issue and validity of the Warrants is conditional, amongst other things, on the passing of the Resolutions and Admission becoming effective on or before 8.00 a.m. on 9 January 2023 (or such later date as finnCap and the Company may agree being not later than 5.30 p.m. on 27 January 2023).

12.  Open Offer

In order to provide Shareholders with an opportunity to participate, the Company is inviting all Qualifying Shareholders to subscribe at the Issue Price for an aggregate of 149,999,860 Open Offer Shares at the Issue Price.

The Directors who hold Ordinary Shares, representing in aggregate approximately 18.27 per cent. of the Company's current issued share capital as at the date of this document, will not be participating in the Open Offer.

Qualifying Shareholders are being given the opportunity to apply for additional Open Offer Shares in excess of their pro rata entitlements. The Open Offer Shares have not been placed subject to clawback and have not been underwritten.

The latest time for applications under the Open Offer to be received is 11.00 a.m. on 5 January 2023. The procedure for application and payment depends on whether, at the time at which application and payment is made, you have an Application Form in respect of your Open Offer Entitlements or have Open Offer Entitlements credited to your stock account in CREST in respect of such entitlement. Further details of the Open Offer are set out in Part II of this document.

13.  Actions to be taken

Please check that you have received the following with this document:

·      A reply-paid Form of Proxy for use in respect of the General Meeting.

You are strongly encouraged to complete, sign and return your Form of Proxy in accordance with the instructions printed thereon as soon as possible, but in any event so as to be received, by post or, during normal business hours only, by hand, by no later than 10.00 a.m. on 4 January 2023 (or, in the case of an adjournment of the General Meeting, not later than 48 hours before the time fixed for the holding of the adjourned meeting).

If you hold your shares in the Company in uncertificated form (that is, in CREST) you may vote using the CREST Proxy Voting service in accordance with the procedures set out in the CREST Manual (please also refer to the accompanying notes to the Notice of the General Meeting set out at the end of this document). Proxies submitted via CREST must be received by the Company's Registrar (Equiniti) by no later than 10.00 a.m. on 4 January 2023 (or, in the case of an adjournment, not later than 48 hours before the time fixed for the holding of the adjourned meeting).

Appointing a proxy in accordance with the instructions set out above will enable your vote to be counted at the General Meeting. The action to be taken by Qualifying Shareholders in connection with the Open Offer is set out in Part II of this document.

If you are in any doubt as to what action you should take, you should immediately seek your own personal financial advice from your stockbroker, bank manager, solicitor, accountant or other independent professional adviser duly authorised under the FSMA if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

14.  Recommendation and Importance of the vote

In proposing the terms of the Fundraising, the Board has pursued a number of routes to raising funds including agreeing the advance payment from the UK EV OEM. However, the Board believes it has now exhausted any potentially more attractive routes that could have been capable of delivering sufficient funds in time with sufficient certainty and has been left with no alternative but to proceed with the Fundraising at a very significant discount and with the issue of the Warrants. The Board understands the implications for Shareholders and has given Shareholders who have not participated in the Placing the opportunity to participate in the fundraising through the Open Offer.

Shareholders should be aware that if the Resolutions are not approved at the General Meeting, the Fundraising will not occur and the net proceeds will not be received by the Company. If this were to happen, to continue to trade, the Group would have to find urgent alternative funding and the Board do not believe that sufficient funding would be available in time to avoid an insolvency event.

The Directors believe that the Resolutions to be proposed at the General Meeting are in the best interests of the Company and Shareholders as a whole and unanimously recommend that Shareholders vote in favour of the Resolutions. The Directors intend to vote in favour of all of the Resolutions in respect of, in aggregate, 6,854,143 Existing Ordinary Shares, representing approximately 18.27 per cent. of the Existing Ordinary Shares.

Yours faithfully

Ian Griffiths
Chairman

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

Record date for entitlements under the Open Offer                                                                         close of business on

12 December 2022

Ex-entitlement date for Open Offer                                                                                                                    8.00 a.m. on

14 December 2022

Publication of this document, Form of Proxy and Application Form                                                 15 December 2022

Open Offer Entitlements and Excess CREST Open Offer Entitlements                                                           8.00 a.m. on

credited to stock accounts of Qualifying CREST Shareholders                                                           16 December 2022

Recommended latest time for withdrawal of Open Offer Entitlements                                                        4.30 p.m. on

from CREST                                                                                                                                                  29 December 2022

Latest time for depositing Open Offer in to CREST                                                       3.00 p.m. on 30 December 2022

Latest time and date for splitting of Application Forms                                                       3.00 p.m. on 3 January 2023

(to satisfy bona fide market claims only)

Latest time and date for receipt of Forms of Proxy                                                            10.00 a.m. on 4 January 2023

Latest time and date for receipt of completed Application Forms                                                              11.00 a.m. on

and payment in full under the Open Offer                                                                                                   5 January 2023

General Meeting                                                                                                                                                   10.00 a.m. on

6 January 2023

Record date for sub-division and creation of Deferred Shares                                                                      6.00 p.m. on

6 January 2023

Announcement of the results of the General Meeting and Open Offer                                                 6 January 2023

Admission and commencement of dealings in the Placing Shares,                                                                8.00 a.m. on

Subscription Shares and the Open Offer Shares on AIM                                                                            9 January 2023

CREST accounts credited in respect of Placing Shares, Subscription                                    On or soon after 8.00 a.m.

Shares and Open Offer Shares in uncertificated form                                                                          on 9 January 2023

Dispatch of definitive share certificates for Placing Shares, Subscription                                             19 January 2023

Shares and Open Offer Shares in certificated form

Notes:

1.        Each of the times and dates above are indicative only and are subject to change. If any of the above times and/or dates change, the revised times and/or dates will be notified by the Company to Shareholders by announcement through a regulatory information service.

2.        All of the above times refer to London time unless otherwise stated.

3.        The admission and commencement of dealings in the Placing, Open Offer and Subscription Shares on AIM are conditional on, inter alia, the passing of the Resolutions at the General Meeting.

4.        If you have any further questions, please call the Shareholder Helpline on 0371-384 2050. The Shareholder Helpline will be open between 8.30 a.m. and 5.30 p.m. (London time), Monday to Friday (excluding public holidays in England and Wales). Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. Different charges may apply to calls to the Shareholder Helplines from mobile telephones and calls may be recorded and randomly monitored for security and training purposes. For legal reasons, the Shareholder Helpline will only be able to provide information contained in this document and information relating to the Company's register of members and will be unable to give advice on the merits of the Fundraising or provide legal, financial, tax or investment advice.

5.        Shareholders should take independent advice if they wish to consider the suitability of these risks with regard to their own particular circumstances and investment criteria.

6.        Copies of this document will be available for inspection free of charge at the registered office of the Company and at Gateley plc (at One Eleven Edmund Street, Birmingham, B3 2HJ) during normal business hours on any Business Day from the date of this document up to and including the date of Admission.

ISSUE STATISTICS

Number of Existing Ordinary Shares                                                                                                                     37,508,065

Issue Price                                                                                                                                                                        1 pence

Number of Placing Shares                                                                                                                                     364,224,700

Number of Subscription Shares                                                                                                                                   300,000

Number of Open Offer Shares¹                                                                                                                           149,999,860

Proceeds of the Fundraising (before expenses)²                                                                                             £5.15 million

Enlarged Share Capital following Admission²                                                                                                     552,032,625

Percentage of Enlarged Share Capital represented by the Placing Shares,                                            93.21 per cent.

the Subscription Shares and the Open Offer Shares²

Market Capitalisation of the Company at the Issue Price upon Admission¹                                                 £5.52 million

Notes:

1.        Assuming the Open Offer is taken up in full

2.        Assuming full issuance of the Placing Shares, Subscription Shares and Open Offer Shares

DEFINITIONS

The following definitions apply throughout the Letter from the Chairman unless the context requires otherwise:

"Admission"                                                    the admission of the Placing Share, the Subscription Shares and the Open Offer Shares to trading on AIM becoming effective in accordance with the AIM Rules

"AIM"                                                               AIM, a market operated by the London Stock Exchange

"AIM Rules"                                                    the AIM Rules for Companies published by the London Stock Exchange from time to time

"Application Form"                                       the personalised application form to be posted to Qualifying Shareholders for use in connection with the Open Offer

"Board" or "Directors"                                  the directors of the Company whose names are set out on page 7 of this document

"Business Day"                                               any day on which banks are usually open in England and Wales for the transaction of sterling business, other than a Saturday, Sunday or public holiday

"certificated" or "in                                       a share or other security not held in uncertificated form (that is, not

certificated form"                                         in CREST)

"Chairman"                                                     the chairman of the Board

"Company" or "Trackwise"                          Trackwise Designs plc, a company incorporated in England and Wales with registered number 03959572

"CREST"                                                            a relevant system (as defined in the CREST Regulations) in respect of which Euroclear is the Operator (as defined in the CREST Regulations)

"CREST Manual"                                             the CREST Manual referred to in agreements entered into by Euroclear and available at www.euroclear.com

"CREST member"                                           a person who has been admitted to CREST as a system-member (as defined in the CREST Regulations)

"CREST member account ID"                       the identification code or number attached to a member account in CREST

"CREST participant"                                       a person who is, in relation to CREST, a system-participant (as defined in the CREST Regulations)

"CREST participant ID"                                  shall have the meaning given in the CREST Manual

"CREST payment"                                          shall have the meaning given in the CREST Manual

"CREST Regulations"                                      the Uncertificated Securities Regulations 2001 (SI 2001/3755) as amended from time to time

"CREST sponsor"                                            a CREST participant admitted to CREST as a CREST sponsor

"CREST sponsored member"                       a CREST member admitted to CREST as a CREST sponsored member

"Enlarged Share Capital"                             the issued share capital of the Company immediately after Admission as enlarged by the issue and allotment of the Placing Shares, Subscription Shares and the Open Offer Shares

"Excess Application Facility"                        the arrangement under which Qualifying Shareholders may apply for any number of Open Offer Shares in excess of their own Open Offer Entitlement

"Excess CREST Open                                      in respect of each Qualifying Shareholder the entitlement (in addition

Offer Entitlement"                                       to their own Open Offer Entitlement) to apply for Open Offer Shares pursuant to the Excess Application Facility

"Existing Ordinary Shares"                           the issued share capital of the Company as at the date of this document, being 37,508,065 Ordinary Shares

"Euroclear"                                                     Euroclear UK & International Limited

"Financial Conduct                                         the Financial Conduct Authority (and its predecessor, the Financial

Authority" or "FCA"                                      Services Authority) in its capacity as the competent authority for the purposes of Part VI of FSMA

"Form of Proxy"                                             the enclosed form of proxy for use by Shareholders in connection with the General Meeting

"FSMA"                                                            the Financial Services and Markets Act 2000 (as amended)

"Fundraising"                                                  the Placing, the Subscription and the Open Offer

"General Meeting"                                        the general meeting of the Company to be held at 10.00 a.m. on 6 January 2023 (or any reconvened meeting following any adjournment of the general meeting), notice of which is set out in this document

"IHT"                                                                Improved Harness Technology^TM, being flexible multilayer printed circuit boards of unlimited length

"Issue Price"                                                   1 pence per New Ordinary Share

"London Stock Exchange"                            London Stock Exchange plc

"Money Laundering Regulations"                the money laundering and terrorist financing provisions of the Criminal Justice Act 1993, the Terrorism Act 2000, the Proceeds of Crime Act 2002, the Terrorism Act 2006 and the Money Laundering Regulations 2007, the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017

"New Ordinary Shares"                        the new Ordinary Shares, being ordinary shares of £0.01 each to be issued by the Company pursuant to the Fundraising

"Notice" or "Notice of                              the notice of the General Meeting set out in this document General Meeting"

"Open Offer"                                              the offer to Qualifying Shareholders, being an invitation to apply for Open Offer Shares on the terms and conditions set out in this document and, where applicable, the Application Form

"Open Offer Entitlement"                           an entitlement of a Qualifying Shareholder pursuant to the Open Offer to apply for 1 Open Offer Share for every 0.250054 Existing Ordinary Shares held by them at the Record Date

 "Open Offer Shares"                                    the 149,999,860 New Ordinary Shares which are the subject of the Open Offer

"Ordinary Shares"                                         existing ordinary shares of 4 pence each in the share capital of the Company

"Overseas Shareholders"                         shareholders who are resident in or a citizen of a country outside the United Kingdom

"Placees"                                                         subscribers for the Placing Shares

"Placing"                                                          the conditional placing by finnCap, as agent of and on behalf of the Company, of the Placing Shares on behalf of the Company on the terms and subject to the conditions contained in the Placing Agreement

"Placing Agreement"                                    the conditional placing agreement dated 14 December 2022 between the Company and finnCap relating to the Placing

"Placing Shares"                                             the New Ordinary Shares to be issued to Placees pursuant to the Placing

"Proposals"                                        the Placing, Subscription and the Open Offer and other matters contained in this document

"Prospectus Rules"                                    the rules made by the FCA under Part VI of FSMA in relation to offers of transferable securities to the public and admission of transferable securities to trading on a regulated market

"Qualifying CREST Shareholders"           Qualifying Shareholders holding Existing Ordinary Shares in uncertificated form via CREST

"Qualifying non-CREST                                  Qualifying Shareholders holding Existing Ordinary Shares in

Shareholders"                                                certificated form

"Qualifying Shareholders"                           shareholders whose Ordinary Shares are on the register on the Record Date with the exception of Overseas Shareholders

"Resolutions"                                                 the resolutions to be proposed at the General Meeting, as set out in the Notice of General Meeting

"Restricted Jurisdiction"                              United States of America, Canada, Australia, Japan, New Zealand and the Republic of South Africa and any other jurisdiction where the extension or availability of the Fundraising would breach any applicable law

"Shareholders"                                              holders of Ordinary Shares

"Stevenage Circuits"                                     Stevenage Circuits Limited, a subsidiary of Trackwise Designs plc, company registered number 01059497.

"Subscriber"                                                   the subscriber for the Subscription Shares pursuant to the Subscription

"Subscription"                                                the subscription of 300,000 New Ordinary Shares by the Subscriber pursuant to the Subscription Letter

"Subscription Letter"                                   the conditional subscription letter dated 14 December 2022 between the Company and the Subscriber in connection with the Subscription

"Subscription Shares"                                   the 300,000 New Ordinary Shares allotted and to be issued pursuant to the Subscription Letter

"Stock account"                                              an account within a member's account in CREST to which a holding of a particular share or other security in CREST is credited

"uncertificated" or "in                                  recorded on the register of members of the Company as being held

uncertificated form"                                     in uncertificated form in CREST and title to which, by virtue of the CREST Regulations, may be transferred by means of CREST

"United Kingdom" or "UK"                          the United Kingdom of Great Britain and Northern Ireland

"UK Listing Authority"                                  the FCA acting in its capacity as the competent authority for the purposes of Part VI of FSMA

"United States" or "US"                               the United States of America

"Warrant Exercise Period"                          the period of three years from the date of Admission

"Warrant Instrument"                                 the instrument creating the Warrants, to be approved at General Meeting

"Warrants"                                                     warrants to subscribe for New Ordinary Shares, details of which are set out in this document

"£", "pounds sterling", "penny"                  UK pounds sterling, the lawful currency of the United Kingdom or "pence"

Important information

This Announcement is for information purposes only and does not itself constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities in the Company and does not constitute investment advice.

Neither this Announcement nor any copy of it may be taken or transmitted, published or distributed, directly or indirectly, in or into the United States, Australia, New Zealand, Canada, Japan, the Republic of South Africa or the Republic of Ireland or to any persons in any of those jurisdictions or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. Any failure to comply with this restriction may constitute a violation of the securities laws of any state or territory of the United States, Australia, New Zealand, Canada, Japan, the Republic of South Africa or the Republic of Ireland. The distribution of this Announcement in other jurisdictions may be restricted by law and persons into whose possession this Announcement comes should inform themselves about, and observe any such restrictions.

Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Neither this Announcement nor any part of it nor the fact of its distribution shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

In particular, the Placing Shares have not been and will not be registered under the US Securities Act, or under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly the Placing Shares may not be offered, sold, pledged or transferred, directly or indirectly, in, into or within the United States except pursuant to an exemption from the registration requirements of the US Securities Act and the securities laws of any relevant state or other jurisdiction of the United States. There is no intention to register any portion of the Placing in the United States or to conduct a public offering of securities in the United States or elsewhere.

finnCap is authorised and regulated in the United Kingdom by the FCA and is acting as nominated adviser and Broker to the Company in respect of the Placing. finnCap is acting for the Company and for no-one else in connection with the Placing, and will not be treating any other person as its client in relation thereto, and will not be responsible for providing the regulatory protections afforded to its customers nor for providing advice in connection with the Placing or any other matters referred to herein and apart from the responsibilities and liabilities (if any) imposed on finnCap, as the case may be, by FSMA, any liability therefor is expressly disclaimed. Any other person in receipt of this Announcement should seek their own independent legal, investment and tax advice as they see fit.

Forward-looking statements

This Announcement contains statements about the Company that are, or may be deemed to be, "forward-looking statements".

All statements, other than statements of historical facts, included in this Announcement may be forward-looking statements. Without limitation, any statements preceded or followed by, or that include, the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "should", "anticipates", "estimates", "projects", "would", "could", "continue" or words or terms of similar substance or the negative thereof, are forward-looking statements. Forward-looking statements include, without limitation, statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects and (ii) business and management strategies and the expansion and growth of the operations of the Company.

These forward-looking statements are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of any such person, or industry results, to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of such persons and the environment in which each will operate in the future. Investors should not place undue reliance on such forward-looking statements and, save as is required by law or regulation (including to meet the requirements of the AIM Rules for Companies, the Prospectus Rules, the FSMA and/or MAR), does not undertake any obligation to update publicly or revise any forward-looking statements (including to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based). All subsequent oral or written forward-looking statements attributed to the Company or any persons acting on their behalf are expressly qualified in their entirety by the cautionary statement above. All forward-looking statements contained in this Announcement are based on information available to the Directors at the date of this Announcement, unless some other time is specified in relation to them, and the posting or receipt of this Announcement shall not give rise to any implication that there has been no change in the facts set forth herein since such date.

APPENDIX - TERMS AND CONDITIONS OF THE PLACING

IMPORTANT INFORMATION FOR INVITED PLACEES ONLY REGARDING THE PLACING.

MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THE ANNOUNCEMENT REGARDING THE PLACING (THE "ANNOUNCEMENT") AND THE TERMS AND CONDITIONS SET OUT HEREIN ("TERMS AND CONDITIONS") ARE DIRECTED ONLY AT PERSONS WHOSE ORDINARY ACTIVITIES INVOLVE THEM IN ACQUIRING, HOLDING, MANAGING AND DISPOSING OF INVESTMENTS (AS PRINCIPAL OR AGENT) FOR THE PURPOSES OF THEIR BUSINESS AND WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS AND ARE: (A) IF IN A MEMBER STATE OF THE EUROPEAN ECONOMIC AREA ("EEA"), QUALIFIED INVESTORS AS DEFINED IN ARTICLE 2(e) OF REGULATION (EU) 2017/1129 (THE "EU PROSPECTUS REGULATION"); (B) IF IN THE UNITED KINGDOM, QUALIFIED INVESTORS AS DEFINED IN ARTICLE 2(e) OF REGULATION (EU) 2017/1129 WHICH FORMS PART OF DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (THE "UK PROSPECTUS REGULATION") WHO ALSO (I) FALL WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") (INVESTMENT PROFESSIONALS); (II) FALL WITHIN ARTICLE 49(2)(a) TO (d) (HIGH NET WORTH COMPANIES, UNINCORPORATED ASSOCIATIONS, ETC.) OF THE ORDER; OR (C) PERSONS TO WHOM THEY MAY OTHERWISE LAWFULLY BE COMMUNICATED (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS "RELEVANT PERSONS").

THE ANNOUNCEMENT AND THE TERMS AND CONDITIONS AND THE INFORMATION THEREIN MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. PERSONS DISTRIBUTING THE ANNOUNCEMENT AND/OR THE TERMS AND CONDITIONS MUST SATISFY THEMSELVES THAT IT IS LAWFUL TO DO SO. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THE TERMS AND CONDITIONS RELATE IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS. THE ANNOUNCEMENT AND THE TERMS AND CONDITIONS DO NOT THEMSELVES CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN TRACKWISE DESIGNS PLC.

THE PLACING SHARES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR UNDER THE APPLICABLE SECURITIES LAWS OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY STATE OR JURISDICTION OF THE UNITED STATES, AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION OF THE UNITED STATES. THE PLACING SHARES ARE BEING OFFERED AND SOLD ONLY OUTSIDE THE UNITED STATES IN "OFFSHORE TRANSACTIONS" WITHIN THE MEANING OF, AND IN ACCORDANCE WITH, REGULATION S UNDER THE SECURITIES ACT AND OTHERWISE IN ACCORDANCE WITH APPLICABLE LAWS. NO PUBLIC OFFERING OF THE PLACING SHARES IS BEING MADE IN THE UNITED STATES OR ELSEWHERE.

THE ANNOUNCEMENT AND THE TERMS AND CONDITIONS ARE RESTRICTED AND ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, THE REPUBLIC OF IRELAND, AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA, OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

The distribution of the Announcement and/or the Terms and Conditions and/or the Placing and/or issue of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company, the Bookrunner or any of its respective affiliates, agents, directors, officers or employees that would permit an offer of the Placing Shares or possession or distribution of the Announcement and/or the Terms and Conditions or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession the Announcement and/or these Terms and Conditions come are required by the Company and the Bookrunner to inform themselves about and to observe any such restrictions.

The Announcement and these Terms and Conditions or any part of them are for information purposes only and do not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, the Republic of Ireland, Australia, New Zealand, Canada, the Republic of South Africa or Japan or any other jurisdiction in which the same would be unlawful. No public offering of the Placing Shares is being made in any such jurisdiction.

In the United Kingdom, the Announcement and these Terms and Conditions are being directed solely at persons in circumstances in which section 21(1) of the Financial Services and Markets Act 2000 (as amended) (the "FSMA") does not apply.

The Placing Shares have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of the Announcement and these Terms and Conditions or the Circular. Any representation to the contrary is a criminal offence in the United States. The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada, no prospectus has been lodged with, or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; the relevant clearances have not been, and will not be, obtained for the South Africa Reserve Bank or any other applicable body in the Republic of South Africa in relation to the Placing Shares and the Placing Shares have not been, nor will they be, registered under or offering in compliance with the securities laws of any state, province or territory of Australia, New Zealand, Canada, the Republic of Ireland, the Republic of South Africa or Japan. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into Australia, New Zealand, the Republic of Ireland, the United States, Canada, the Republic of South Africa or Japan or any other jurisdiction in which such offer, sale, re-sale or delivery would be unlawful.

Persons (including, without limitation, nominees and trustees) who have a contractual right or other legal obligations to forward a copy of the Announcement (or any part of it) and/or these Terms and Conditions should seek appropriate advice before taking any action.

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II ("MiFID II Delegated Directive"); and (c) local implementing measures, (including insofar as MiFID II and the MiFID II Delegated Directive constitute retained EU law (as defined in section 6(7) of the European Union (Withdrawal) Act 2018) in the United Kingdom) ("Retained MiFID Provisions") (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that the Placing Shares are: (i) compatible with an end target market of (a) retail investors, (b) investors who meet the criteria of professional clients and (c) eligible counterparties, each as defined in MiFID II and the Retained MiFID Provisions; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II or the Retained MiFID Provisions (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the bookrunner will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II or the Retained MiFID Provisions; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares.

Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

The Terms and Conditions should be read in their entirety. 

Key Terms and Dates

In addition to the definitions set out at the end of these Terms and Conditions, the following defined terms and dates are relevant to these Terms and Conditions:

Details of the Placing Agreement and the Placing Shares

The Bookrunner has entered into the Placing Agreement with the Company under which, on the terms and subject to the conditions set out in the Placing Agreement, the Bookrunner, as agent for and on behalf of the Company, has agreed to use its reasonable endeavours to procure Placees for the Placing Shares at the Issue Price. The Placing is not being underwritten in whole or in part by either the Bookrunner or any other person.

The exact number of Placing Shares to be allocated and issued to Placees shall be determined by the Bookrunner and the Company following completion of the Bookbuild (as defined below).

The Placing Shares will, when issued, be subject to the memorandum and articles of association of the Company and credited as fully paid and will rank pari passu in all respects with the existing issued Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid in respect of such Ordinary Shares on or after the date of issue of the Placing Shares.

Accelerated bookbuilding process

Commencing today, the Bookrunner will be conducting an accelerated bookbuilding process to determine demand for participation in the Placing by Placees (the "Bookbuild"). The Announcement gives details of the terms and conditions of, and the mechanics of participation in, the Placing. However, the Bookrunner will be entitled to effect the Placing by such alternative method to the Bookbuild as they may, after consultation with the Company, determine.

A bid in the Bookbuild will be made on these Terms and Conditions which are attached to the Announcement and will be legally binding on the Placee on behalf of which it is made and, except with the Bookrunner's consent, will not be capable of variation or revocation after the Recorded Commitment has concluded.

The book will open with immediate effect. The final number of Placing Shares to be issued pursuant to the Placing will be agreed by the Bookrunner and the Company at the close of the Bookbuild, and the result of the Placing will be announced as soon as practicable thereafter. The timing for the close of the Bookbuild and the allocation of the Placing Shares shall be at the absolute discretion of the Bookrunner, in consultation with the Company. The Bookrunner reserves the right increase the Placing and will inform the Placees as soon as soon reasonably practicable.

To the fullest extent permissible by law, neither:

(a)         the Bookrunner;

(b)         any of its respective affiliates, agents, advisers, directors, officers, consultants or employees; nor

(c)         to the extent not contained within (a) or (b), any person connected with the Bookrunner as defined in the FSMA ((b) and (c) being together "affiliates" and individually an "affiliate" of the Bookrunner),

shall have any liability (including to the extent permissible by law, any fiduciary duties) to Placees or to any other person whether acting on behalf of a Placee or otherwise. In particular neither the Bookrunner nor any of its respective affiliates shall have any liability (including, to the extent legally permissible, any fiduciary duties), in respect of their conduct of the Bookbuild or of such alternative method of effecting the Placing as the Bookrunner may determine.

By participating in the Placing (such participation up to an agreed maximum level to be confirmed in and evidenced by either (i) a recorded telephone call or (ii) email correspondence, in either case between representatives of the Bookrunner to whom the Placee's commitment is given and the relevant Placee (a "Recorded Commitment")), each Placee will be deemed to have read and understood the Announcement and these Terms and Conditions in their entirety, to be participating and acquiring Placing Shares on these Terms and Conditions and to be providing the representations, warranties, indemnities, acknowledgements and undertakings contained in these Terms and Conditions.

In particular, each such Placee irrevocably represents, warrants, undertakes, agrees and acknowledges (amongst other things) severally to the Company and the Bookrunner that:

1.            it is a Relevant Person and that it will acquire, hold, manage or dispose of any Placing Shares that are allocated to it for the purposes of its business;

2.            in the case of a Relevant Person in the United Kingdom who acquires any Placing Shares pursuant to the Placing:

(d)   it is a Qualified Investor within the meaning of Article 2(e) of the UK Prospectus Regulation; and

(e)   in the case of any Placing Shares acquired by it as a financial intermediary, as that term is used in Article 5(1) of the UK Prospectus Regulation:

(i)         the Placing Shares acquired by it in the Placing have not been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in the United Kingdom other than Qualified Investors or in circumstances in which the prior consent of the Bookrunner has been given to the offer or resale; or

(ii)         where Placing Shares have been acquired by it on behalf of persons in the United Kingdom other than Qualified Investors, the offer of those Placing Shares to it is not treated under the UK Prospectus Regulation as having been made to such persons; and

3.            in the case of a Relevant Person in a member state of the EEA (each, a "Relevant State") who acquires any Placing Shares pursuant to the Placing:

(a)   it is a Qualified Investor within the meaning of Article 2(e) of the EU Prospectus Regulation;

(b)   in the case of any Placing Shares acquired by it as a financial intermediary, as that term is used in Article 5(1) of the EU Prospectus Regulation:

(i)         the Placing Shares acquired by it in the Placing have not been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in a Relevant State other than Qualified Investors or in circumstances in which the prior consent of the Bookrunner has been given to the offer or resale; or

(ii)         where Placing Shares have been acquired by it on behalf of persons in a Relevant State other than Qualified Investors, the offer of those Placing Shares to it is not treated under the EU Prospectus Regulation as having been made to such persons;

4.            it is acquiring the Placing Shares solely for its own account or is acquiring the Placing Shares for an account with respect to which it exercises sole investment discretion and has the authority to make and does make the representations, warranties, indemnities, acknowledgements, undertakings and agreements contained in these Terms and Conditions;

5.            it understands (or if acting for the account of another person, such person has confirmed that such person understands) and agrees to comply with the resale and transfer restrictions set out in these Terms and Conditions; and

6.            except as otherwise permitted by the Company and subject to any available exemptions from applicable securities laws, it (and any account referred to in paragraph 4 above) is outside the United States acquiring the Placing Shares in offshore transactions as defined in and in accordance with Regulation S under the Securities Act.

No prospectus

The Placing Shares are being offered to a limited number of specifically invited persons only and will not be offered in such a way as to require any prospectus or other offering document to be published. No prospectus or other offering document has been or will be submitted to be approved by the Financial Conduct Authority ("FCA") in relation to the Placing or the Placing Shares and Placees' commitments will be made solely on the basis of the information contained in the Announcement and any information publicly announced through a Regulatory Information Service (as defined in the AIM Rules for Companies (the "AIM Rules")) by or on behalf of the Company on or prior to the date of these Terms and Conditions (the "Publicly Available Information") and subject to any further terms set forth in writing in any contract note sent to an individual Placee.

Each Placee, by participating in the Placing, agrees that the content of the Announcement is exclusively the responsibility of the Company and confirms that it has neither received nor relied on any information (other than the Publicly Available Information), representation, warranty or statement made by or on behalf of the Bookrunner or the Company or any other person and none of the Bookrunner, the Company nor any other person acting on such person's behalf nor any of their respective affiliates has or shall have any liability for any Placee's decision to participate in the Placing based on any other information, representation, warranty or statement. Each Placee acknowledges and agrees that it has relied on its own investigation of the business, financial or other position of the Company in accepting a participation in the Placing. No Placee should consider any information in the Announcement or these Terms and Conditions to be legal, tax, business or other advice. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation.

Application for admission to trading

Application(s) will be made to the London Stock Exchange for admission of the Placing Shares to trading on AIM.

It is expected that Admission will take place on the Admission Date and that dealings in the Placing Shares on AIM will commence at the same time.

Principal terms of the Placing

finnCap is acting as nominated adviser and sole broker to the Placing, as agent for and on behalf of the Company.

Participation in the Placing is by invitation only and will only be available to persons who may lawfully be, and are, invited by the Bookrunner to participate. The Bookrunner and any of its respective affiliates are entitled to participate in the Placing as principal.

Each Placee will confirm the maximum number of Placing Shares it is willing to acquire in a Recorded Commitment. Once they have made a Recorded Commitment, each Placee will have an immediate, separate, irrevocable and binding obligation, owed to the Bookrunner (as agent for the Company), to subscribe and pay for, at the Issue Price, the number of Placing Shares allocated to it, up to the agreed maximum.

Each Placee's allocation (and whether such Placee participates in the Placing) will be determined by the Bookrunner in their discretion following consultation with the Company and will be confirmed by the Bookrunner either orally or in writing via a contract note after the Recorded Commitment has taken place.

Each Placee's commitment will be confirmed in and evidenced by a Recorded Commitment. These Terms and Conditions will be deemed incorporated into each contract which is entered into by way of a Recorded Commitment and will be legally binding on the relevant Placee(s) on behalf of whom the commitment is made with effect from the end of the Recorded Commitment and, except with the Bookrunner's prior written consent, will not be capable of variation or revocation after such time. A contract note confirming each Placee's allocation of Placing Shares will be sent to them following the Recorded Commitment and the allocation process. These Terms and Conditions shall be deemed incorporated into any such contract note.

Each Placee will have an immediate, separate, irrevocable and binding obligation, owed to the Bookrunner (as agent for the Company), to pay to it (or as it may direct) in cleared funds an amount equal to the product of the Issue Price and the number of Placing Shares allocated to such Placee (subject always to such Placee's agreed maximum).

The Bookrunner's reserve the right to scale back the number of Placing Shares to be subscribed by any Placee in the event that the Placing is oversubscribed. The Bookrunner also reserves the right not to accept offers to subscribe for Placing Shares or to accept such offers in part rather than in whole. The acceptance and, if applicable, scaling back of offers shall be at the absolute discretion of the Bookrunner (in consultation with the Company).

Except as required by law or regulation, no press release or other announcement will be made by the Bookrunner or the Company using the name of any Placee (or its agent), in its capacity as Placee (or agent), other than with such Placee's prior written consent (save as required by any law or regulation).

Irrespective of the time at which a Placee's allocation(s) pursuant to the Placing is/are confirmed, settlement for all Placing Shares to be acquired pursuant to the Placing will be required to be made at the same time on the basis explained below under "Registration and settlement".

All obligations under the Placing will be subject to fulfilment of the conditions referred to below under "Conditions of the Placing" and to the Placing not being terminated on the basis referred to below under "Termination of the Placing".

By participating in the Placing, each Placee agrees that its rights and obligations in respect of the Placing will terminate only in the circumstances described below and will not be capable of rescission or termination by the Placee.

Registration and settlement

By participating in the Placing, each Placee will be deemed to agree that it will do all things necessary to ensure that delivery and payment is completed as directed by the Bookrunner in accordance with either the standing CREST or certificated settlement instructions which they have in place with the Bookrunner.

Settlement of transactions in the Placing Shares following Admission will take place within the CREST system, subject to certain exceptions. Settlement through CREST will be on a delivery versus payment basis ("DVP") unless otherwise notified by the Bookrunner and is expected to occur on the Settlement Date. 

In the event of any difficulties or delays in the admission of any Placing Shares to CREST or the use of CREST in relation to the Placing, the Company and the Bookrunner may agree that the Placing Shares (or any of them) should be issued in certificated form. The Bookrunner reserves the right to require settlement for any of the Placing Shares, and to deliver any of the Placing Shares to any Placees, by such other means as it deems necessary if delivery or settlement to any Placee is not practicable within the CREST system or would not be consistent with regulatory requirements in the jurisdiction in which a Placee is located.

Interest is chargeable daily on payments not received from Placees on or before the due date in accordance with the arrangements set out above, in respect of either CREST or certificated deliveries, at the rate of 3 percentage points above the prevailing base rate of Barclays Bank plc as determined by the Bookrunner.

Each Placee is deemed to agree that if it does not comply with these obligations, the Bookrunner may sell any or all of their Placing Shares on their behalf and retain from the proceeds, for the Bookrunner's own account and benefit, an amount equal to the aggregate amount owed by the Placee plus any interest due. The relevant Placee will, however, remain liable for any shortfall below the Issue Price and for any stamp duty or stamp duty reserve tax (together with any interest or penalties) which may arise upon the sale of its Placing Shares on its behalf.

If Placing Shares are to be delivered to a custodian or settlement agent, Placees must ensure that, upon receipt, any relevant contract note is copied and delivered immediately to the relevant person within that organisation. Insofar as Placing Shares are registered in a Placee's name or that of its nominee or in the name of any person for whom a Placee is contracting as agent or that of a nominee for such person, such Placing Shares should, subject as provided below, be so registered free from any liability to United Kingdom stamp duty or stamp duty reserve tax. Placees will not be entitled to receive any fee or commission in connection with the Placing.

Conditions of the Placing

The Placing is conditional upon the Placing Agreement becoming unconditional and not having been terminated in accordance with its terms.

The obligations of the Bookrunner's under the Placing Agreement are, and the Placing is, conditional upon, inter alia:

(a)           the Resolutions being passed at the General Meeting;

(b)           the warranties and undertakings contained in the Placing Agreement ("Warranties") being true, accurate and not misleading when made on the date of the Placing Agreement and at all times up to Admission by reference to the facts and circumstances subsisting at that time;

(c)           the Company having fully performed its obligations under the Placing Agreement to the extent that they fall to be performed prior to Admission;

(d)           the Bookrunner not having exercised its right to terminate the Placing Agreement; and

(e)           Admission having become effective at or around the Admission Date;

(all conditions to the obligations of the Bookrunner included in the Placing Agreement being together, the "conditions").

If any of the conditions is not fulfilled or, where permitted, waived in accordance with the Placing Agreement within the stated time periods (or such later time and/or date as the Company and the Bookrunner may agree), or the Placing Agreement is terminated in accordance with its terms, the Placing (or such part of it as may then remain to be completed) will lapse and the Placee's rights and obligations shall cease and terminate at such time and each Placee agrees that no claim can be made by or on behalf of the Placee (or any person on whose behalf the Placee is acting) in respect thereof.

By participating in the Placing, each Placee agrees that its rights and obligations cease and terminate only in the circumstances described above and under "Termination of the Placing" below and will not be capable of rescission or termination by it.

The Bookrunner may, in its absolute discretion (but acting together) and upon such terms as it thinks fit, waive fulfilment of all or any of the conditions in the Placing Agreement in whole or in part, or extend the time provided for fulfilment of one or more conditions, save that certain conditions (including the condition relating to Admission referred to in paragraph (e) above) may not be waived. Any such extension or waiver will not affect Placees' commitments as set out in these Terms and Conditions.

The Bookrunner may terminate the Placing Agreement in certain circumstances, details of which are set out below.

Neither the Bookrunner nor any of its respective affiliates, agents, advisers, directors, officers or employees nor the Company shall have any liability to any Placee (or to any other person whether acting on behalf of a Placee or otherwise) in respect of any decision any of them may make as to whether or not to waive or to extend the time and/or date for the satisfaction of any condition to the Placing (or any part thereof) nor for any decision any of them may make as to the satisfaction of any condition or in respect of the Placing generally (or any part thereof) and by participating in the Placing each Placee agrees that any such decision is within the absolute discretion of the Bookrunner.

Termination of the Placing

Save as set out below, the Bookrunner may, in its absolute discretion, by notice to the Company, terminate the Placing Agreement at any time up to Admission if, inter alia, it is of the opinion, in its absolute discretion, that any of the following has occurred and it is, as a result of such matter, inappropriate to proceed with the Placing:

(a)           any statement contained in the Circular or any other document or announcement issued or published by or on behalf of the Company in connection with the Placing ("Issue Documents") has become untrue, inaccurate or misleading or any matter has arisen which would, if the Issue Documents were issued at that time, constitute a material omission from the Issue Documents or any of them;

(b)           any of the Warranties was untrue, inaccurate or misleading when made and/or that any of the Warranties has ceased to be true or accurate or has become misleading at any time prior to Admission, in each case by reference to the facts and circumstances subsisting at that time;

(c)           the Company has not complied or cannot comply with any of its obligations under the Placing Agreement or otherwise relating to the Placing and Admission (to the extent that such obligations fall to be complied with prior to Admission);

(d)           there has occurred any material adverse change in the financial position or prospects of the Company (or its group on a consolidated basis); or

(e)           there has occurred any change in national or international financial, monetary, market (including fluctuations in exchange rates), industrial, economic, legal or political conditions or there has occurred or been a material worsening of any international or national crisis, civil unrest, act of terrorism or outbreak of hostilities which is material in the context of the Placing.

If the Placing Agreement is terminated in accordance with its terms, the rights and obligations of each Placee in respect of the Placing as described in these Terms and Conditions shall cease and terminate at such time and no claim can be made by any Placee in respect thereof.

By participating in the Placing, each Placee agrees with the Company and the Bookrunner that the exercise by the Company or the Bookrunner of any right of termination or any other right or other discretion under the Placing Agreement shall be within the absolute discretion of the Company or the Bookrunner or for agreement between the Company and the Bookrunner (as the case may be) and that neither the Company nor the Bookrunner need make any reference to such Placee and that none of the Company, the Bookrunner nor any of its respective affiliates, agents, advisers, directors, officers or employees shall have any liability to such Placee (or to any other person whether acting on behalf of a Placee or otherwise) whatsoever in connection with any such exercise.

By agreeing with a Bookrunner (as agent of the Company) to subscribe for Placing Shares under the Placing, a Placee (and any person acting on a Placee's behalf) will irrevocably acknowledge and confirm and warrant and undertake to, and agree with, each of the Company and the Bookrunner, in each case as a fundamental term of such Placee's application for Placing Shares and of the Company's obligation to allot and/or issue any Placing Shares to it or at its direction, that its rights and obligations in respect of the Placing (or any part of it) will terminate only in the circumstances described above and under the "Conditions of the Placing" section above and will not be capable of rescission or termination by it in any other circumstances.

Representations, warranties and further terms

By participating in the Placing, each Placee (and any person acting on such Placee's behalf) represents, warrants, acknowledges, undertakes, confirms and agrees (for itself and for any such prospective Placee) that (save where the Bookrunner expressly agrees in writing to the contrary):

1.            it has read and understood the Announcement and these Terms and Conditions in their entirety and its acquisition of Placing Shares is subject to and based upon all the terms, conditions, representations, warranties, indemnities, acknowledgements, agreements and undertakings and other information contained herein and it has not relied on, and will not rely on, any information given or any representations, warranties or statements made at any time by any person in connection with Admission, the Placing, the Company, the Placing Shares or otherwise, other than the information contained in the Announcement and the Publicly Available Information;

2.            it has not received a prospectus or other offering document in connection with the Placing and acknowledges that no prospectus or other offering document:

(a)           is required under any applicable law; or

(b)           has been or will be prepared in connection with the Placing

and, in particular, that the Subscription and Open Offer referred to in the Announcement and the Circular relating thereto are separate from the Placing and do not form part of any offer or agreement concerning the Placing and/or any Placing Shares (although do not prohibit the Placees from participating in the Open Offer should they choose to do so);

3.            the Ordinary Shares are admitted to trading on AIM, and that the Company is therefore required to publish certain business and financial information in accordance with the AIM Rules and the Market Abuse Regulation (EU Regulation No. 596/2014 which forms part of domestic law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR")), which includes a description of the nature of the Company's business and the Company's most recent statement of financial position and statement of total comprehensive income and that it is able to obtain or access such information without undue difficulty, and is able to obtain access to such information or comparable information concerning any other publicly traded company, without undue difficulty;

4.            it has made its own assessment of the Placing Shares and has relied on its own investigation of the business, financial position and other aspects of the Company in accepting a participation in the Placing and neither the Bookrunner nor the Company nor any of their respective affiliates, agents, advisers, directors, officers or employees nor any person acting on behalf of any of them has provided, and will not provide, it with any material regarding the Placing Shares or the Company or any other person other than the information in the Announcement and these Terms and Conditions or the Publicly Available Information; nor has it requested the Bookrunner, the Company, any of their respective affiliates, agents, advisers, directors, employees or officers or any person acting on behalf of any of them to provide it with any such information;

5.            neither the Bookrunner nor any person acting on behalf of it nor any of their respective affiliates, agents, directors, officers or employees has or shall have any liability for any Publicly Available Information, or any representation relating to the Company, provided that nothing in these Terms and Conditions excludes the liability of any person for any fraudulent misrepresentation made by that person;

6.            the only information on which it is entitled to rely on and on which it has relied in committing to acquire the Placing Shares is contained in the Announcement and the Publicly Available Information, such information being all that it deems necessary to make an investment decision in respect of the Placing Shares and it has made its own assessment of the Company, the Placing Shares and the terms of the Placing based on the Announcement and the Publicly Available Information;

7.            neither the Bookrunner nor any of its respective affiliates, agents, directors, officers or employees have made any representation or warranty to it, express or implied, with respect to the Company, the Placing or the Placing Shares or the accuracy, completeness or adequacy of the Announcement, the Circular or the Publicly Available Information;

8.            it has conducted its own investigation of the Company, the Placing and the Placing Shares, satisfied itself that the information is still current and relied on that investigation for the purposes of its decision to participate in the Placing;

9.            it has not relied on any investigation that the Bookrunner or any person acting on its behalf may have conducted with respect to the Company, the Placing or the Placing Shares;

10.          the contents of the Announcement, the Circular and the other Publicly Available Information as well as any information made available (in written or oral form) in presentations or as part of roadshow discussions with investors relating to the Company (the "Information") has been prepared by and is exclusively the responsibility of the Company and neither the Bookrunner nor any persons acting on their behalf is responsible for or has or shall have any liability for any such Information, or for any representation, warranty or statement relating to the Company contained therein nor will they be liable for any Placee's decision to participate in the Placing based on any Information or any representation, warranty or statement contained therein or otherwise;

11.          it has the funds available to pay for the Placing Shares which it has agreed to acquire and acknowledges and agrees that it will pay the total subscription amount in accordance with the Announcement and these Terms and Conditions by the due time and date set out herein, failing which the relevant Placing Shares may be placed with other Placees or sold at such price as the Bookrunner determines;

12.          it and/or each person on whose behalf it is participating:

(a)           is entitled to acquire Placing Shares pursuant to the Placing under the laws and regulations of all relevant jurisdictions;

(b)           has fully observed such laws and regulations;

(c)           has capacity and authority and is entitled to enter into and perform its obligations as an acquirer of Placing Shares and will honour such obligations; and

(d)           has obtained all necessary consents and authorities (including, without limitation, in the case of a person acting on behalf of a Placee, all necessary consents and authorities to agree to the terms set out or referred to in these Terms and Conditions) under those laws or otherwise and complied with all necessary formalities to enable it to enter into the transactions contemplated hereby and to perform its obligations in relation thereto and, in particular, if it is a pension fund or investment company it is aware of and acknowledges it is required to comply with all applicable laws and regulations with respect to its acquisition of Placing Shares;

13.          it is not, and any person who it is acting on behalf of is not, and at the time the Placing Shares are acquired will not be, a resident of, or with an address in, or subject to the laws of, Australia, New Zealand, the Republic of Ireland, Canada, the Republic of South Africa or Japan, and it acknowledges and agrees that the Placing Shares have not been and will not be registered or otherwise qualified under the securities legislation of Australia, New Zealand, the Republic of Ireland, Canada, the Republic of South Africa or Japan and may not be offered, sold, or acquired, directly or indirectly, within those jurisdictions;

14.          it and the beneficial owner of the Placing Shares is, and at the time the Placing Shares are acquired will be, outside the United States and acquiring the Placing Shares in an "offshore transaction" as defined in, and in accordance with, Regulation S under the Securities Act;

15.          it understands that the Placing Shares have not been, and will not be, registered under the Securities Act and may not be offered, sold or resold in or into or from the United States except pursuant to an effective registration under the Securities Act, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with applicable state securities laws; and no representation is being made as to the availability of any exemption under the Securities Act for the reoffer, resale, pledge or transfer of the Placing Shares;

16.          it (and any account for which it is purchasing) is not acquiring the Placing Shares with a view to any offer, sale or distribution thereof within the meaning of the Securities Act;

17.          it will not distribute, forward, transfer or otherwise transmit the Announcement or these Terms and Conditions and/or the Circular or any part of them, or any other presentational or other materials concerning the Placing in or into or from the United States (including electronic copies thereof) to any person, and it has not distributed, forwarded, transferred or otherwise transmitted any such materials to any person;

18.          neither the Bookrunner, its respective affiliates and/or any person acting on behalf of any of them is making any recommendations to it or advising it regarding the suitability of any transactions it may enter into in connection with the Placing and that participation in the Placing is on the basis that it is not and will not be a client of either of the Bookrunner and that the Bookrunner has no duties or responsibilities to it for providing the protections afforded to its clients or for providing advice in relation to the Placing nor in respect of any representations, warranties, undertakings or indemnities contained in the Placing Agreement nor for the exercise or performance of any of its rights and obligations thereunder including any rights to waive or vary any conditions or exercise any termination right;

19.          it will make payment to the Bookrunner for the Placing Shares allocated to it in accordance with these Terms and Conditions on or by Settlement Date, failing which the relevant Placing Shares may be placed with others on such terms as the Bookrunner determines in its absolute discretion without liability to the Placee and it will remain liable for any shortfall below the net proceeds of such sale and the placing proceeds of such Placing Shares and may be required to bear any stamp duty or stamp duty reserve tax (together with any interest or penalties due pursuant to the terms set out or referred to in these Terms and Conditions) which may arise upon the sale of such Placee's Placing Shares on its behalf;

20.          its Recorded Commitment to acquire Placing Shares will represent a maximum number of Placing Shares which it may be required to subscribe for, and that following the allocation process the Bookrunner may call upon it to subscribe for a lower number of Placing Shares (if any), but in no event in aggregate more than the aforementioned maximum;

21.          no action has been or will be taken by any of the Company, the Bookrunner or any person acting on behalf of the Company or the Bookrunner that would, or is intended to, permit a public offer of the Placing Shares in the United States or in any country or jurisdiction where any such action for that purpose is required;

22.          the person who it specifies for registration as holder of the Placing Shares will be:

(a)           the Placee; or

(b)           a nominee of the Placee, as the case may be;

23.          neither the Bookrunner nor the Company will be responsible for any liability to stamp duty or stamp duty reserve tax resulting from a failure to observe the above requirement. Each Placee and any person acting on behalf of such Placee agrees to acquire Placing Shares pursuant to the Placing and agrees to indemnify the Company and the Bookrunner in respect of the same on the basis that the Placing Shares will be allotted to a CREST stock account of the Bookrunner or transferred to a CREST stock account of the Bookrunner who will hold them as nominee on behalf of the Placee until settlement in accordance with its standing settlement instructions with it;

24.          the allocation, allotment, issue and delivery to it, or the person specified by it for registration as holder, of Placing Shares will not give rise to a stamp duty or stamp duty reserve tax liability under (or at a rate determined under) any of sections 67, 70, 93 or 96 of the Finance Act 1986 (depository receipts and clearance services) and it is not participating in the Placing as nominee or agent for any person or persons to whom the allocation, allotment, issue or delivery of Placing Shares would give rise to such a liability;

25.          if it is within the United Kingdom, it and any person acting on its behalf (if within the United Kingdom) falls within Article 19(5) and/or 49(2) of the Order and undertakes that it will acquire, hold, manage and (if applicable) dispose of any Placing Shares that are allocated to it for the purposes of its business only;

26.          it has not offered or sold and will not offer or sell any Placing Shares to persons in the United Kingdom except to persons whose ordinary activities involve them in acquiring, holding, managing or disposing of investments (as principal or agent) for the purposes of their business or otherwise in circumstances which have not resulted and which will not result in an offer to the public in the United Kingdom within the meaning of section 85(1) of the FSMA or an offer to the public in any other member state of the EEA within the meaning of the UK Prospectus Regulation, or an offer to the public in any Relevant State within the meaning of the EU Prospectus Regulation;

27.          it has only communicated or caused to be communicated and it will only communicate or cause to be communicated any invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) relating to Placing Shares in circumstances in which section 21(1) of the FSMA does not require approval of the communication by an authorised person and it acknowledges and agrees that neither the Announcement, these Terms and Conditions nor the Circular has been or will be approved by the Bookrunner in its capacity as an authorised person under section 21 of the FSMA and it may not therefore be subject to the controls which would apply if it was made or approved as a financial promotion by an authorised person;

28.          it has complied and it will comply with all applicable laws in any jurisdiction with respect to anything done by it or on its behalf in relation to the Placing Shares (including all relevant provisions of the FSMA and UK MAR in respect of anything done in, from or otherwise involving the United Kingdom);

29.          the Placing Shares acquired by it in the Placing will not be acquired on a non-discretionary basis on behalf of, nor will they be acquired with a view to their offer or resale to any person save in circumstances in which the express prior written consent of the Bookrunner has been given to the offer or resale;

30.          if it has received any inside information (for the purposes of UK MAR and/or section 56 of the Criminal Justice Act 1993 or other applicable law) about the Company in advance of the Placing, it has not:

(a)           dealt (or attempted to deal) in the securities of the Company;

(b)           encouraged, recommended or induced another person to deal in the securities of the Company; or

(c)           unlawfully disclosed such information to any person, prior to the information being made publicly available;

31.          neither the Bookrunner, the Company nor any of their respective affiliates, agents, advisers, directors, officers or employees nor any person acting on behalf of the Bookrunner or the Company or their respective affiliates, agents, advisers, directors, officers or employees nor any person acting on behalf of any of them is making any recommendations to it, advising it regarding the suitability of any transactions it may enter into in connection with the Placing nor providing advice in relation to the Placing nor in respect of any representations, warranties, acknowledgements, agreements, undertakings, or indemnities contained in the Placing Agreement nor the exercise or performance of the Bookrunner's rights and obligations thereunder including any rights to waive or vary any conditions or exercise any termination right;

32.          either the Bookrunner and its respective affiliates, acting as an investor for its or their own account(s), may bid or subscribe for and/or purchase Placing Shares and, in that capacity, may retain, purchase, offer to sell or otherwise deal for its or their own account(s) in the Placing Shares, any other securities of the Company or other related investments in connection with the Placing or otherwise. Accordingly, references in these Terms and Conditions and/or the Announcement to the Placing Shares being offered, subscribed, acquired or otherwise dealt with should be read as including any offer to, or subscription, acquisition or dealing by, the Bookrunner and/or any of its respective affiliates acting as an investor for its or their own account(s). Neither the Bookrunner nor the Company intend to disclose the extent of any such investment or transaction otherwise than in accordance with any legal or regulatory obligation to do so;

33.          it:

(a)           has complied, and will comply, with its obligations in connection with money laundering and terrorist financing under the Proceeds of Crime Act 2002, the Terrorism Act 2000, the Terrorism Act 2006 and the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 (in each case as amended);

(b)           is not a person:

(i)            with whom transactions are prohibited under the US Foreign Corrupt Practices Act of 1977 or any economic sanction programmes administered by, or regulations promulgated by, the Office of Foreign Assets Control of the U.S. Department of the Treasury;

(ii)           named on the Consolidated List of Financial Sanctions Targets maintained by HM Treasury of the United Kingdom; or

(iii)          subject to financial sanctions imposed pursuant to a regulation of the European Union or a regulation adopted by the United Nations or other applicable law,

(all such statutes, rules and regulations referred to in this paragraph 33 together, the "Regulations") and if making payment on behalf of a third party, that satisfactory evidence has been obtained and recorded by it to verify the identity of the third party as required by the Regulations and has obtained all governmental and other consents (if any) which may be required for the purpose of, or as a consequence of, such purchase, and it will provide promptly to the Bookrunner such evidence, if any, as to the identity or location or legal status of any person which it may request from it in connection with the Placing (for the purpose of complying with the Regulations or ascertaining the nationality of any person or the jurisdiction(s) to which any person is subject or otherwise) in the form and manner requested by the Bookrunner on the basis that any failure by it to do so may result in the number of Placing Shares that are to be acquired by it or at its direction pursuant to the Placing being reduced to such number, or to nil, as the Bookrunner may decide at its sole discretion;

34.          in order to ensure compliance with the Regulations, the Bookrunner (for itself and as agent on behalf of the Company) or the Company's registrars may, in their absolute discretion, require verification of its identity. Pending the provision to the Bookrunner or the Company's registrars, as applicable, of evidence of identity, definitive certificates in respect of the Placing Shares may be retained at the Bookrunner's absolute discretion or, where appropriate, delivery of the Placing Shares to it in uncertificated form may be delayed at the Bookrunner's or the Company's registrars', as the case may be, absolute discretion. If within a reasonable time after a request for verification of identity the Bookrunner (for itself and as agent on behalf of the Company) or the Company's registrars have not received evidence satisfactory to them, either the Bookrunner and/or the Company may, at its absolute discretion, terminate its commitment in respect of the Placing, in which event the monies payable on acceptance of allotment will, if already paid, be returned without interest to the account of the drawee's bank from which they were originally debited;

35.          its commitment to acquire Placing Shares on the Terms and Conditions will continue notwithstanding any amendment that may in future be made to the terms and conditions of the Placing and that Placees will have no right to be consulted or require that their consent be obtained with respect to the Company's or any Bookrunner's conduct of the Placing;

36.          neither of the Bookrunnernor any of its respective affiliates, agents, advisers, directors, officers or employees makes any representation in respect of or shall have any responsibility for the tax treatment that any Placee may receive or expect in relation to their investment in Placing Shares;

37.          it has knowledge and experience in financial, business and international investment matters as is required to evaluate the merits and risks of acquiring the Placing Shares. It further acknowledges that it is experienced in investing in securities of this nature and is aware that it may be required to bear, and is able to bear, the economic risk of, and is able to sustain, a complete loss in connection with the Placing. It has relied upon its own examination and due diligence of the Company and its affiliates taken as a whole, and the terms of the Placing, including the merits and risks involved;

38.          it irrevocably appoints any duly authorised officer of the Bookrunner as its agent for the purpose of executing and delivering to the Company and/or its registrars any documents on its behalf necessary to enable it to be registered as the holder of any of the Placing Shares which it agrees to acquire upon these Terms and Conditions;

39.          the Company, the Bookrunner and others (including each of their respective affiliates, agents, advisers, directors, officers and employees) will rely upon the truth and accuracy of the foregoing representations, warranties, acknowledgements and agreements, which are given to each of the Bookrunner on their own behalf and on behalf of the Company and are irrevocable;

40.          it is acting as principal only in respect of the Placing or, if it is acquiring the Placing Shares as a fiduciary or agent for one or more investor accounts, it is duly authorised to do so and it has full power and authority to make, and does make, the foregoing representations, warranties, acknowledgements, agreements and undertakings on behalf of each such accounts;

41.          time is of the essence as regards its obligations under these Terms and Conditions;

42.          any document that is to be sent to it in connection with the Placing will be sent at its risk and may be sent to it at any address provided by it to the Bookrunner;

43.          the Placing Shares will be issued subject to these Terms and Conditions; and

44.          these Terms and Conditions and all documents into which these Terms and Conditions are incorporated by reference or otherwise validly forms a part and/or any agreements entered into pursuant to these Terms and Conditions and all agreements to acquire Placing Shares pursuant to the Placing will be governed by and construed in accordance with English law and it submits to the exclusive jurisdiction of the English courts in relation to any claim, dispute (contractual or otherwise) or matter arising out of or in connection with such contract except that enforcement proceedings in respect of the obligation to make payment for the Placing Shares (together with interest chargeable thereon) may be taken by the Company or the Bookrunner in any jurisdiction in which the relevant Placee is incorporated or in which any of its securities have a quotation on a recognised stock exchange.

By participating in the Placing, each Placee (and any person acting on such Placee's behalf) agrees to indemnify and hold the Company, the Bookrunner and each of their respective affiliates, agents, directors, officers and employees harmless from any and all costs, claims, liabilities and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations, warranties, acknowledgements, agreements and undertakings given by the Placee (and any person acting on such Placee's behalf) in these Terms and Conditions or incurred by the Bookrunner, the Company or any of their respective affiliates, agents, directors, officers or employees arising from the non-performance of the Placee's obligations as set out in these Terms and Conditions, and further agrees that the provisions of these Terms and Conditions shall survive after the completion of the Placing.

The agreement to allot and issue Placing Shares to Placees (or the persons for whom Placees are contracting as agent) free of stamp duty and stamp duty reserve tax in the United Kingdom relates only to their allotment and issue to Placees, or such persons as they nominate as their agents, direct by the Company. Such agreement assumes that the Placing Shares are not being acquired in connection with arrangements to issue depositary receipts or to transfer the Placing Shares into a clearance service. If there are any such arrangements, or the settlement related to any other dealings in the Placing Shares, stamp duty or stamp duty reserve tax may be payable. In that event, the Placee agrees that it shall be responsible for such stamp duty or stamp duty reserve tax and neither the Company nor the Bookrunner shall be responsible for such stamp duty or stamp duty reserve tax. If this is the case, each Placee should seek its own advice and they should notify the Bookrunner accordingly. In addition, Placees should note that they will be liable for any capital duty, stamp duty and all other stamp, issue, securities, transfer, registration, documentary or other duties or taxes (including any interest, fines or penalties relating thereto) payable outside the United Kingdom by them or any other person on the acquisition by them of any Placing Shares or the agreement by them to acquire any Placing Shares and each Placee, or the Placee's nominee, in respect of whom (or in respect of the person for whom it is participating in the Placing as an agent or nominee) the allocation, allotment, issue or delivery of Placing Shares has given rise to such non-United Kingdom stamp, registration, documentary, transfer or similar taxes or duties undertakes to pay such taxes and duties, including any interest and penalties (if applicable), forthwith and to indemnify on an after-tax basis and to hold harmless the Company and the Bookrunner in the event that any of the Company and/or the Bookrunner has incurred any such liability to such taxes or duties.

The representations, warranties, acknowledgements and undertakings contained in these Terms and Conditions are given to the Bookrunner for itself and on behalf of the Company and are irrevocable.

The Bookrunner is authorised and regulated by the FCA in the United Kingdom and are acting exclusively for the Company and no one else in connection with the Placing, and will not be responsible to anyone (including any Placees) other than the Company for providing the protections afforded to their clients or for providing advice in relation to the Placing or any other matters referred to in these Terms and Conditions.

Each Placee and any person acting on behalf of the Placee acknowledges that the Bookrunner does not owe any fiduciary or other duties to any Placee in respect of any representations, warranties, undertakings, acknowledgements, agreements or indemnities in the Placing Agreement.

The provisions of these Terms and Conditions may be varied, waived or modified as regards specific Placees or on a general basis by the Bookrunner provided always that such variation, waiver or modification is not materially prejudicial to the interests of the Company.

In the case of a joint agreement to acquire Placing Shares, references to a "Placee" in these Terms and Conditions are to each of such Placees and such joint Placees' liability is joint and several.

Each Placee and any person acting on behalf of the Placee acknowledges and agrees that the Bookrunner may (at its absolute discretion) satisfy its obligations to procure Placees by itself agreeing to become a Placee in respect of some or all of the Placing Shares or by nominating any connected or associated person to do so.

When a Placee or any person acting on behalf of the Placee is dealing with a Bookrunner, any money held in an account with the Bookrunner on behalf of the Placee and/or any person acting on behalf of the Placee will not be treated as client money within the meaning of the relevant rules and regulations of the FCA made under the FSMA. Each Placee acknowledges that the money will not be subject to the protections conferred by the client money rules: as a consequence this money will not be segregated from the Bookrunner's money in accordance with the client money rules and will be held by it under a banking relationship and not as trustee.

In these Terms and Conditions any words following the terms "including", "include", "in particular", "for example" or any similar expression shall be construed as illustrative and shall not limit the sense of the words, description, definition, phrase or term preceding those terms.

References to time in the Terms and Conditions are to London time, unless otherwise stated.

All times and dates in these Terms and Conditions may be subject to amendment. Placees will be notified of any changes.

No statement in the Announcement, these Terms and Conditions or the Circular is intended to be a profit forecast or estimate, and no statement in the Announcement, these Terms and Conditions or the Circular should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.

The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser.

The Placing Shares to be issued pursuant to the Placing will not be admitted to trading on any stock exchange other than AIM.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, these Terms and Conditions and/or the Announcement.

DEFINITIONS

In this Announcement the following terms have the associated meanings: